1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow this drug Literature Review of Intensity modulated total marrow irradiation trials Research Report on Intensity modulated total marrow irradiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS) Intensity modulated total marrow irradiation, Cyclophosphamide (CTX), Fludarabine (Fludara) - Acute Myeloid Leukemia, Relapsed, Adult, Acute Myeloid Leukemia Refractory | Phase 2 | Recruiting | University of Illinois at Chicago | 38 | 2025-02-04 | 2026-06-26 |
Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1) · Recurrence (1)
University of Illinois at Chicago (1)
United States (1)